CancerLinQ Developing De-Identified Datasets for Quality Improvement | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

CancerLinQ Developing De-Identified Datasets for Quality Improvement

December 22, 2017
by
| Reprints

CancerLinQ LLC, a wholly-owned non-profit subsidiary of the American Society of Clinical Oncology (ASCO), announced new partnerships with data services companies Tempus and Precision HealthAI in order to accelerate development and delivery of high-quality, de-identified clinical databases for use by CancerLinQ, its oncologist subscribers, partners, and the broader cancer community.

The agreement will also enable CancerLinQ to more quickly build and expand on its core data sharing and quality improvement platform for oncology practices, and facilitate Tempus' and Precision HealthAI's connection to industry to support faster and better development of new treatments for patients, according to a CancerLinQ press release.

Through the new agreement, Tempus and Precision HealthAI will curate data into high-quality datasets to be used to improve quality of cancer care and for research. These datasets will be made available through the core CancerLinQ quality improvement platform and CancerLinQ Discovery, a service that provides access to high-quality, de-identified datasets for non-profit organizations, health care providers, academic researchers, and government agencies.

Tempus and Precision HealthAI will bring these de-identified datasets to industry partners to produce practical applications such as targeted therapies, more efficient clinical trials, and data-driven analyses to help determine which therapies are producing the greatest patient benefit. Royalties from this license will help to support ASCO's CancerLinQ initiative, according to the organization.

Under the new license arrangement, CancerLinQ will retain its non-profit status and remain responsible for data integration and providing a platform of meaningful tools and reports to participating oncologists and oncology care sites. Tempus and Precision HealthAI will be responsible for further structuring this dataset to put it to work for the benefit of patients.  

"Our commitment to oncologists and the patients they serve is stronger than ever and this collaboration will allow us to deliver cutting-edge clinical tools and enhanced benefits to the cancer centers participating in CancerLinQ,” CancerLinQ LLC chief executive officer Kevin Fitzpatrick said in a statement. “As a result of the technical and financial contributions of Tempus and Precision HealthAI, CancerLinQ aims to accelerate the pace of new quality improvement services to its subscribers.”

CancerLinQ recently reached a key milestone with more than 100 oncology practices in 40 states and the District of Columbia now signed up to participate. They account for more than 2,000 medical oncologists and have contributed more than a million cancer patient records in the database. 

 

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

KLAS Research: Small Hospitals’ Buying Decisions Impacting EMR Market Share

A new KLAS Research report tracks shifts in electronic medical record (EMR) vendor market share among acute care hospitals, and finds that smaller hospitals are seeking technology solutions that meet their needs and limited budgets, and these contracts are making a mark on the EMR market.

Survey: Majority of Providers Predict Success for New Generic Drug Company, Project Rx

Back in January, four health systems, in consultation with the VA, announced a collaboration to develop a new, not-for-profit generic drug company. A survey has found that 90 percent of providers say they would become customers of the new venture.

Personalized Medicine Awareness Low Among U.S. Adults, Survey Finds

Genetics and personalized medicine are not top of mind for the general public in the U.S., according to a recent survey from GenomeWeb and the Personalized Medicine Coalition.

Industry Organizations Praise Senate Passage of VA Mission Act

The U.S. Senate on Wednesday passed, by a vote of 92-5, a major Veterans Affairs (VA) reform bill that includes health IT-related provisions to improve health data exchange between VA healthcare providers and community care providers.

NIH Issues Funding Announcement for All of Us Genomic Research Program

The National Institutes of Health’s (NIH) “All of Us” Research Program has issued a funding announcement for genome centers to generate genotype and whole genome sequence data from participants’ biosamples.

MGMA: Physician Compensation Data Illustrates Nationwide PCP Shortage

Primary care physicians’ compensation rose by more than 10 percent over the past five years, representing an increase which is nearly double that of specialty physicians’ compensation over the same period, according to the Medical Group Management Association (MGMA).